09 December 2022
LeydenJar secures EU backing in financing of new battery factory
- Scaling up energy innovation and products
- Development of battery technology and applications
Last week, Kempenhaeghe and Aristotle Technologies signed a cooperation agreement to develop this training tool for children with neurological learning and development disorders, such as congenital and non-congenital brain injury as well as Duchenne muscular dystrophy, neurofibromatosis (NF-1) and epilepsy. Dr. Jos Hendriksen, Kempenhaeghe clinical neuropsychologist: "There is a big challenge because these children's learning is threatened by brain-related problems. The earlier can be started with training tailored to the brain, the greater and broader the effect on learning performance and behavior also in later life. Also remember that learning and behavioral functioning and building self-confidence go hand in hand and mutually influence each other."
Within Kempenhaeghe a 'testing ground' will be set up to see if the developed training matches the experiential world of school children. During the training children will receive feedback on their performance, allowing them to adjust their behavior immediately. New training tools will be developed with new individual exercises and tasks to further train the brain. The training tool will also be used in the outpatient clinic of Kempenhaeghe's Center for Neurological Learning and Developmental Disorders.
Aristotle Technologies and Kempenhaeghe got to know each other through a collaboration with the PSV Academy Eindhoven. In this unique collaboration, on the one hand there are children with a healthy brain and a talent for movement and soccer, and on the other hand children with a neurological disorder for whom learning and movement are threatened. The resulting joint expertise can lead to new insights and methodologies both in the field of diagnostics and care and in the guidance and training within the PSV Academy.